Tissue factor and angiogenesis in cancer

Current Opinion in Hematology

Volumn 9, Issue 5, 2002, Pages 401-406

  Fernandez, Patricia M ^a   Rickles, Frederick R ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN;

ANGIOGENESIS; ANIMAL TISSUE; CANCER GROWTH; CANCER PATIENT; FIBROBLAST; GENE TARGETING; GENETIC PREDISPOSITION; HYPERCOAGULABILITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THROMBOSIS; TUMOR GROWTH; ANIMAL; BLOOD CLOTTING; HUMAN; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; BLOOD COAGULATION; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 0036341469     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200209000-00003     Document Type: Review

References (67)

1. Phlegmasia alba dolens
2. Abnormalities of hemostasis in malignancy
3. Thrombosis in cancer patients
4. Abnormalities of hemostasis in malignant disease
5. Molecular mechanisms linking thrombosis and angiogenesis in cancer
6. Pathogenic mechanisms of thrombosis in malignancy
7. Molecular basis for the relationship between thrombosis and cancer
8. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: Tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer
9. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation
10. Role of tissue factor in embryonic blood vessel development
11. Targeted disruption of the murine tissue factor gene results in embryonic lethality
12. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
13. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
14. Cell biology of tissue factor, the principal initiator of blood coagulation
15. Cellular consequences upon factor VIIa binding to tissue factor
16. Structure and biology of tissue factor pathway inhibitor
17. Cell biology of tissue factor, an unusual member of the cytokine receptor family
18. Expression of tissue factor in human stroma correlates with progression to invasive human breast cancer
19. Tissue factor expression in human colorectal carcinoma. Correlation with hepatic metastasis and impact on prognosis
20. Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor
21. Expression of tissue factor correlates with grade of malignancy in human glioma
22. Quantitative reverse transcription-PCR measurement of tissue factor mRNA in glioma
23. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human giiomas
24. Molecular cloning, expression and partial characterization of a novel human tissue factor pathway inhibitor
25. Elevated plasma levels of the factor Xa-TFPI complex in cancer patients
26. Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion
27. Tissue factor expression and multidrug resistance in cancer: Two aspects of a common cellular response to a hostile milieu
28. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma
29. Tissue factor - A receptor involved in the control of cellular properties, including angiogenesis
30. The biology and tumor-related properties of monocyte tissue factor
31. Tissue factor expression in non-small cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis
32. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
33. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice
34. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer
35. Regulation of vascular endothelial growth production and angiogenesis by the cytoplasmic tail of tissue factor
36. The blood platelet as a model for regulating blood coagulation on cell surfaces and its consequences
37. Platelets and cancer: Implications for antiangiogenic therapy
38. Fibrin induction of tissue factor expression in human vascular endothelial cells
39. Fibrin activation of vascular endothelial cells: Induction of IL-8 expression
40. Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: Production of IL-6 and IL-8 in monocytes by fibrin clots
41. Clotting factors build blood vessels
42. Protease-activated receptors in vascular biology
43. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets
44. Cellular effects of initiation of the extrinsic pathway of blood coagulation
45. The pleiotropic effects of tissue factor: A possible role for factor VIIa-induced intracellular signalling?
46. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor
47. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor
48. Coagulation factors VIIa and Xa induce cell signaling leading to upregulation of the egr-1 gene
49. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain
50. Role of tissue factor in metastasis: Functions of the cytoplasmic and extracellular domains of the molecule
51. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa
52. An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression
53. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells
54. Mechanism of tissue factor activation on cells
55. Some thoughts about localization and expression of tissue factor
56. Tissue factor on cells
57. Tissue factor deencryption: Ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms
58. Tissue factor encryption/de-encryption is not altered in the absence of the cytoplasmic domain
59. Manifestation of cryptic fibroblast tissue factor occurs at detergent concentrations which dissolve the plasma membrane
60. Cooperation between VEGF and TNF-α is necessary for exposure of active tissue factor on the surface of human endothelial cells
61. Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway
62. Caveolae-not just crators in the cellular landscape
63. Targeting tissue factor on tumor vasculature endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer
64. Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice
65. Increased risk of deep vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
66. Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors
67. Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: Time to take stock!